Search Results

There are 195838 results for: content related to: Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype

  1. You have free access to this content
    Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network

    Cancer

    Volume 118, Issue 22, 15 November 2012, Pages: 5463–5472, Nancy U. Lin, Ann Vanderplas, Melissa E. Hughes, Richard L. Theriault, Stephen B. Edge, Yu-Ning Wong, Douglas W. Blayney, Joyce C. Niland, Eric P. Winer and Jane C. Weeks

    Version of Record online : 27 APR 2012, DOI: 10.1002/cncr.27581

  2. You have free access to this content
    The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004

    Cancer

    Volume 112, Issue 4, 15 February 2008, Pages: 737–747, Monica Brown, Alex Tsodikov, Katrina R. Bauer, Carol A. Parise and Vincent Caggiano

    Version of Record online : 11 JAN 2008, DOI: 10.1002/cncr.23243

  3. You have free access to this content
    Cytologic features of triple-negative breast carcinoma

    Cancer Cytopathology

    Volume 120, Issue 6, 25 December 2012, Pages: 401–409, Mariella Bonzanini, Luca Morelli, Elena Maria Bonandini, Elena Leonardi, Riccardo Pertile and Paolo Dalla Palma

    Version of Record online : 25 JUL 2012, DOI: 10.1002/cncy.21207

  4. Clinicopathological features and prognosis of triple-negative breast cancer: a comparison between younger (<60) and elderly (≥60) patients

    European Journal of Cancer Care

    J.D. Qiu, X.Y. Xue, R. Li and J.D. Wang

    Version of Record online : 30 JUN 2015, DOI: 10.1111/ecc.12346

  5. You have free access to this content
    Multifocal breast cancer documented in large-format histology sections

    Cancer

    Volume 119, Issue 6, 15 March 2013, Pages: 1132–1139, Gyula Pekar, Syster Hofmeyer, László Tabár, Miklós Tarján, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Sherry Yueh-Hsia Chiu, Dan Hellberg, Mária Gere and Tibor Tot

    Version of Record online : 27 DEC 2012, DOI: 10.1002/cncr.27877

  6. You have full text access to this Open Access content
    Clinical implications for nestin protein expression in breast cancer

    Cancer Science

    Volume 101, Issue 3, March 2010, Pages: 815–819, Caigang Liu, Bo Chen, Jun Zhu, Ruishan Zhang, Fan Yao, Feng Jin, Huimian Xu and Ping Lu

    Version of Record online : 31 OCT 2009, DOI: 10.1111/j.1349-7006.2009.01422.x

  7. You have free access to this content
    Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women

    Cancer

    Volume 119, Issue 3, 1 February 2013, Pages: 488–494, Theresa Schwartz, Azadeh Stark, Judy Pang, Baffour Awuah, Celina G. Kleer, Solomon Quayson, Stephanie Kingman, Francis Aitpillah, Francis Abantanga, Evelyn Jiagge, Joseph K. Oppong, Ernest Osei-Bonsu, Iman Martin, Xiaowei Yan, Kathy Toy, Ernest Adjei, Max Wicha and Lisa A. Newman

    Version of Record online : 28 AUG 2012, DOI: 10.1002/cncr.27737

  8. Increased expression of osteopontin in patients with triple-negative breast cancer

    European Journal of Clinical Investigation

    Volume 38, Issue 6, June 2008, Pages: 438–446, X. Wang, L. Chao, G. Ma, L. Chen, B. Tian, Y. Zang and J. Sun

    Version of Record online : 30 APR 2008, DOI: 10.1111/j.1365-2362.2008.01956.x

  9. You have free access to this content
    The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study

    The Journal of Pathology

    Volume 237, Issue 2, October 2015, Pages: 166–178, Elena Guerini-Rocco, Zsolt Hodi, Salvatore Piscuoglio, Charlotte KY Ng, Emad A Rakha, Anne M Schultheis, Caterina Marchiò, Arnaud da Cruz Paula, Maria R De Filippo, Luciano G Martelotto, Leticia De Mattos-Arruda, Marcia Edelweiss, Achim A Jungbluth, Nicola Fusco, Larry Norton, Britta Weigelt, Ian O Ellis and Jorge S Reis-Filho

    Version of Record online : 29 JUL 2015, DOI: 10.1002/path.4566

  10. You have free access to this content
    Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters

    Cancer

    Volume 112, Issue 5, March 2008, Pages: 995–1000, Sandip Basu, Wengen Chen, Julia Tchou, Ayse Mavi, Tevfik Cermik, Brian Czerniecki, Mitchell Schnall and Abass Alavi

    Version of Record online : 20 DEC 2007, DOI: 10.1002/cncr.23226

  11. You have full text access to this OnlineOpen article
    WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer

    EMBO Molecular Medicine

    Volume 5, Issue 2, February 2013, Pages: 264–279, Peter Wend, Stephanie Runke, Korinna Wend, Brenda Anchondo, Maria Yesayan, Meghan Jardon, Natalie Hardie, Christoph Loddenkemper, Ilya Ulasov, Maciej S. Lesniak, Rebecca Wolsky, Laurent A. Bentolila, Stephen G. Grant, David Elashoff, Stephan Lehr, Jean J. Latimer, Shikha Bose, Husain Sattar, Susan A. Krum and Gustavo A. Miranda-Carboni

    Version of Record online : 11 JAN 2013, DOI: 10.1002/emmm.201201320

  12. Genetic Susceptibility to Triple-Negative Breast Cancers

    Standard Article

    eLS

    Michelle W Wong-Brown and Rodney J Scott

    Published Online : 15 MAY 2014, DOI: 10.1002/9780470015902.a0025352

  13. You have free access to this content
    Triple-negative breast cancer: making the most of a misnomer

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 2, June 2012, Pages: 145–155, Nicole MCCARTHY, Gillian MITCHELL, Michael BILOUS, Nicholas WILCKEN and Geoffrey J. LINDEMAN

    Version of Record online : 24 APR 2012, DOI: 10.1111/j.1743-7563.2012.01533.x

  14. You have free access to this content
    Managing the remaining breast

    Cancer

    Volume 46, Issue S4, 15 August 1980, Pages: 1026–1030, Henry Patrick Leis Jr.

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19800815)46:4+<1026::AID-CNCR2820461327>3.0.CO;2-L

  15. You have free access to this content
    Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy

    Cancer

    Volume 116, Issue 6, 15 March 2010, Pages: 1431–1439, Rohit Bhargava, Sushil Beriwal, David J. Dabbs, Umut Ozbek, Atilla Soran, Ronald R. Johnson, Adam M. Brufsky, Barry C. Lembersky and Gretchen M. Ahrendt

    Version of Record online : 3 FEB 2010, DOI: 10.1002/cncr.24876

    Corrected by:

    Erratum: Erratum: Immunohistochemical Surrogate Markers of Breast Cancer Molecular Classes Predicts Response to Neoadjuvant Chemotherapy

    Vol. 117, Issue 10, 2238, Version of Record online: 10 NOV 2010

  16. You have free access to this content
    Screening for basal marker expression is necessary for decision of therapeutic strategy for triple-negative breast cancer

    Journal of Surgical Oncology

    Volume 97, Issue 1, 1 January 2008, Pages: 30–34, Mitsunori Sasa, Yoshimi Bando, Masako Takahashi, Toshiyuki Hirose and Taeko Nagao

    Version of Record online : 10 OCT 2007, DOI: 10.1002/jso.20906

  17. You have full text access to this Open Access content
    Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma

    Cancer Science

    Volume 102, Issue 5, May 2011, Pages: 1107–1111, Po Zhao, Yali Lu, Xuege Jiang and Xiaoying Li

    Version of Record online : 28 FEB 2011, DOI: 10.1111/j.1349-7006.2011.01894.x

  18. Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple-negative tumours

    Histopathology

    Volume 68, Issue 3, February 2016, Pages: 367–377, Elena Provenzano, David J Byrne, Prudence A Russell, Gavin M Wright, Daniele Generali and Stephen B Fox

    Version of Record online : 7 AUG 2015, DOI: 10.1111/his.12765

  19. A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers

    The Journal of Pathology

    Volume 227, Issue 1, May 2012, Pages: 29–41, Rachael Natrajan, Alan Mackay, Maryou B Lambros, Britta Weigelt, Paul M Wilkerson, Elodie Manie, Anita Grigoriadis, Roger A'Hern, Petra van der Groep, Iwanka Kozarewa, Tatiana Popova, Odette Mariani, Samra Turajlic, Simon J Furney, Richard Marais, Daniel-Nava Rodruigues, Adriana C Flora, Patty Wai, Vidya Pawar, Simon McDade, Jason Carroll, Dominique Stoppa-Lyonnet, Andrew R Green, Ian O Ellis, Charles Swanton, Paul van Diest, Olivier Delattre, Christopher J Lord, William D Foulkes, Anne Vincent-Salomon, Alan Ashworth, Marc Henri Stern and Jorge S Reis-Filho

    Version of Record online : 23 FEB 2012, DOI: 10.1002/path.4003

  20. Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers

    Journal of Magnetic Resonance Imaging

    Volume 36, Issue 1, July 2012, Pages: 145–151, Hye Ryoung Koo, Nariya Cho, In Chan Song, Hyeonjin Kim, Jung Min Chang, Ann Yi, Bo La Yun and Woo Kyung Moon

    Version of Record online : 5 MAR 2012, DOI: 10.1002/jmri.23635